靶向超声造影剂BR55的研究进展
Research Progress of Targeted Ultrasound Contrast Agent BR55
查看参考文献29篇
|
文摘
|
BR55是以血管内皮生长因子受体2为靶点的靶向超声造影剂,可用于检测肿瘤新生血管形成提高诊断准确率。国外已有学者应用BR55进行人体超声分子成像,并显示出良好的安全性和耐受性。本文从BR55组成及特性、动物实验及临床应用等方面对BR55在评估肿瘤新生血管的研究进展进行综述。 |
|
其他语种文摘
|
BR55 is an ultrasound contrast agent targeting vascular endothelial growth factor receptor 2,which can be used to detect tumor neovascularization and improve the diagnostic accuracy.Overseas researchers have used BR55 for human ultrasound molecular imaging,which showed good safety and tolerance.We reviewed the research progress on BR55 applied in the evaluation of tumor neovascularization from the composition,characteristics,animal experiments,and clinical studies of BR55. |
|
来源
|
中国医学科学院学报
,2022,44(1):118-122 【核心库】
|
|
DOI
|
10.3881/j.issn.1000-503X.12934
|
|
关键词
|
靶向超声造影剂
;
超声分子成像
;
血管内皮生长因子受体
|
|
地址
|
1.
中国医学科学院北京协和医学院北京协和医院超声科, 北京, 100730
2.
北京中医药大学房山医院超声科, 北京, 102488
|
|
语种
|
中文 |
|
文献类型
|
综述型 |
|
ISSN
|
1000-503X |
|
学科
|
临床医学 |
|
基金
|
国家自然科学基金
;
中国医学科学院医学与健康科技创新工程
|
|
文献收藏号
|
CSCD:7178359
|
参考文献 共
29
共2页
|
|
1.
陈军. VEGFR2活性腔性质以及与抑制剂的结合模式研究.
化学学报,2007(6):547-552
|
被引
5
次
|
|
|
|
|
2.
伍星.
靶向VEGFR2超声分子显像小鼠H22移植瘤实验研究,2009
|
被引
3
次
|
|
|
|
|
3.
Turco S. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
Phys Med Biol,2017,62(6):2449-2464
|
被引
5
次
|
|
|
|
|
4.
Abou-Elkacem L. Ultrasound molecular imaging:Moving toward clinical translation.
Eur J Radiol,2015,84(9):1685-1693
|
被引
10
次
|
|
|
|
|
5.
汤阳. 超声分子成像在肝癌诊治中的研究进展.
肿瘤影像学,2015,24(2):148-153
|
被引
2
次
|
|
|
|
|
6.
Zhang J. Targeting property and toxicity of a novel ultrasound contrast agent microbubble carrying the targeting and drug-loaded complex FA-CNTs-PTX on MCF7 cells.
Colloids Surf B Biointerfaces,2017,158:16-24
|
被引
2
次
|
|
|
|
|
7.
Ji Y. Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.
Cancer Med,2016,5(9):2534-2543
|
被引
8
次
|
|
|
|
|
8.
Bachawal S V. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.
Cancer Res,2013,73(6):1689-1698
|
被引
8
次
|
|
|
|
|
9.
Smeenge M. First-in-human ultrasound molecular imaging with a VEGFR2-specific ultrasound molecular contrast agent (BR55) in prostate cancer:A safety and feasibility pilot study.
Invest Radiol,2017,52(7):419-427
|
被引
6
次
|
|
|
|
|
10.
Hicklin D J. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
J Clin Oncol,2005,23(5):1011-1027
|
被引
120
次
|
|
|
|
|
11.
Willmann J K. Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions:First-in-human results.
J Clin Oncol,2017,35(19):2133-2140
|
被引
16
次
|
|
|
|
|
12.
Wang S. Targeting of microbubbles:Contrast agents for ultrasound molecular imaging.
J Drug Target,2018,26(5/6):420-434
|
被引
9
次
|
|
|
|
|
13.
Hackl C. Improved detection of preclinical colorectal liver metastases by high resolution ultrasound including molecular ultrasound imaging using the targeted contrast agent BR55.
Ultraschall Med,2016,37(3):290-296
|
被引
3
次
|
|
|
|
|
14.
Pysz M A. Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer.
Quant Imaging Med Surg,2012,2(2):68-80
|
被引
3
次
|
|
|
|
|
15.
Baetke S C. Squamous cell carcinoma xenografts:Use of VEGFR2-targeted microbubbles for combined functional and molecular US to monitor antiangiogenic therapy effects.
Radiology,2016,278(2):430-440
|
被引
4
次
|
|
|
|
|
16.
Mancini M. Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
BMC Med Imaging,2013,13:31
|
被引
5
次
|
|
|
|
|
17.
Zafarnia S. Nilotinib enhances tumor angiogenesis and counteracts VEGFR2 blockade in an orthotopic breast cancer xenograft model with desmoplastic response.
Neoplasia,2017,19(11):896-907
|
被引
3
次
|
|
|
|
|
18.
Pochon S. BR55:A lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Invest Radiol,2010,45(2):89-95
|
被引
15
次
|
|
|
|
|
19.
Wang J. Ultrasound molecular imaging of angiogenesis using vascular endothelial growth factor-conjugated microbubbles.
Mol Pharm,2017,14(3):781-790
|
被引
6
次
|
|
|
|
|
20.
Grouls C. Liver dysplasia:US molecular imaging with targeted contrast agent enables early assessment.
Radiology,2013,267(2):487-495
|
被引
1
次
|
|
|
|
|
了解气象卫星更多信息，请访问